Updated:
RA Capital Management
RA Capital founds, funds, and scales companies across healthcare and planetary health to build a healthier future for all. They pair scientific diligence with...
RA Capital Management
RA Capital founds, funds, and scales companies across healthcare and planetary health to build a healthier future for all. They pair scientific diligence with multi-stage capital and provide hands-on operational insight and support. Since 2004, RA Capital has turned breakthrough science into lasting companies using an evidence-based approach that combines deep research with hands-on partnership.
General information
Firm type
Generalist
Year founded
2004
Location
Region
North America
Country
United States
City
Boston
Corporate office
200 Berkeley St, 18th Floor, Boston, MA 02116
Additional offices
New York, NY · San Francisco, CA
Principals
Peter Kolchinsky
PhD — Managing Partner
Rajeev Shah — Managing Partner
Zach Scheiner
PhD — Partner
Jake Simson
PhD — Partner
Matt Hammond
PhD, MBA — Partner
Derek DiRocco
PhD — Partner
Josh Resnick
MD — Partner
Jeremy Lack
DPhil — Partner
Laura Stoppel
PhD — Partner
Adam Kaye — Senior Managing Director and Partner
Structured Capital
Kyle Teamey — Managing Partner
Brigid O’Brien
PhD — Managing Partner
Michael Saulnier
CPA — Chief Financial Officer
Eric Rose
CPA, CFA — Chief Compliance Officer
Craig Randall — General Counsel
Kady O’Grady — Chief People Officer
Brent Sanders — Chief Information Officer
Sector focus
Frequently asked questions
What is TechAtlas and how does it support RA Capital's investment process?
TechAtlas is an internal division of RA Capital that functions as an independent think tank. It analyzes scientific and clinical data from academic literature and thousands of product development programs. The team collaborates with the investment group to evaluate companies and advise on strategy for portfolio companies. This structure allows RA Capital to originate its own conviction rather than relying on sell-side or third-party research.
Does RA Capital invest only in private companies or does it also take public equity positions?
RA Capital is a multi-stage investment manager active across the full corporate lifecycle. Its strategies include seed, start-up, expansion, late-stage, PIPE, pre-IPO, venture debt, and public equity investing. This hybrid approach allows the firm to provide continuity of capital as companies mature from private to public markets.
How does RA Capital source investment opportunities?
The firm accepts company pitches through a centralized hub team at request@racap.com, which routes non-confidential decks to the most experienced available colleague. RA Capital explicitly discourages direct outreach to its investment staff via LinkedIn or other social media, citing compliance restrictions. Internally, the TechAtlas division independently identifies investment opportunities by mapping competitive landscapes.
What sectors does RA Capital explicitly focus on, and where is it expanding?
RA Capital's primary focus is healthcare and life sciences, including companies developing drugs, medical devices, diagnostics, services, and research tools. The firm states it has a growing interest in climate and sustainability technologies. Publicly available materials do not indicate active investment in software, fintech, or consumer internet outside of these scientific domains.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: